Developer docs
API playgroundTry for free, no card

Search company profiles

Tampa Bay Medical Research

Full company profile

uuid000n8py

Namestring
Tampa Bay Medical Research
Legal namestring
Tampa Bay Medical Research
Websiteurl
tbmr.net
Company typeenum
Private
Founded yearint
1984
Short descriptiontext

Tampa Bay Medical Research was a Florida-based clinical research organization founded in 1984 that conducted Phase I-IV trials for 70+ pharmaceutical and medical device sponsors across multiple therapeutic areas, including metabolic research. It was acquired by Alcanza Clinical Research in January 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersClearwater, United States
HQ citystring
Clearwater
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, clinical trial management, metabolic disease research, pharmaceutical trial services, medical device studies
Industry2 codes
1Clinical CROs (Phase I–IV)
CodeHLAGAAAAPrimaryYes
2Clinical Trial Monitoring Support (On-site/Remote)
CodeHLAGACAGPrimaryNo
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Tampa Bay Medical Research (TBMR) is a clinical research organization (CRO) that conducts Phase I-IV clinical trials for pharmaceutical and medical device sponsors across multiple therapeutic areas. The organization specializes in metabolic research and operates from facilities in Clearwater and Largo, Florida, totaling more than 5,000 square feet.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Phase I-IV Clinical Trials
CategoryClinical Research Services
2Metabolic Disease Clinical Research
CategoryClinical Research Services
3Medical Device Clinical Trials
CategoryClinical Research Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Alcanza Clinical Research
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

Strategic partnership in which Alcanza Clinical Research acquired Tampa Bay Medical Research. The transaction integrates TBMR's operational excellence and community presence into Alcanza's network of 25 dedicated research units across the US and Puerto Rico. Westcove Partners served as exclusive financial advisor to Tampa Bay Medical Research.

Peers10 records
1Medpace
TypeBroad incumbent
Description

Mid-to-large global CRO running Phase I-IV trials across therapeutic areas including metabolic and endocrine. Competes for sponsor outsourced trial work though at materially greater scale than TBMR.

2Syneos Health
TypeBroad incumbent
Description

Global biopharmaceutical solutions organization offering clinical development services and site management solutions. Comparable end-market positioning to TBMR's clinical trial services business.

3Meridien Research
TypeDirect peer
Description

Florida-based clinical research site network with a similar mid-sized site profile. Competes for the same regional pharmaceutical sponsor relationships and patient population TBMR serves.

4ICON plc
TypeBroad incumbent
Description

Global CRO with significant site management (formerly PRA Health, SMO) operations. Operates directly in the same Phase I-IV clinical trial execution category but at an order-of-magnitude larger scale.

5Compass Research
TypeDirect peer
Description

Independent clinical research site headquartered in central Florida, conducting Phase I-IV trials across therapeutic areas. Direct competitor for Tampa Bay-area sponsor contracts and patient recruitment pools.

6Thermo Fisher Scientific (PPD)
TypeBroad incumbent
Description

Operates the PPD clinical research business providing end-to-end CRO services including clinical site management. Larger incumbent in clinical trial execution across all therapeutic areas TBMR serves.

7IQVIA
TypeBroad incumbent
Description

Largest global CRO and clinical research services provider. Operates dedicated site networks (e.g., Q² Solutions) directly overlapping with TBMR's site-based clinical trial execution model.

8Fortrea
TypeBroad incumbent
Description

Spun-out CRO from LabCorp Drug Development offering full-service Phase I-IV clinical trial services. Broadly comparable functional offering to TBMR's clinical research services but with global infrastructure.

9Accel Clinical Research
TypeDirect peer
Description

Multi-site independent clinical research organization operating in the southeastern US. Comparable in size, therapeutic breadth, and sponsor mix to TBMR's pre-acquisition profile.

10Alcanza Clinical Research
TypeDirect peer
Description

Multi-site clinical research network and TBMR's acquirer. Operates dedicated research units across the US and Puerto Rico with a shared CRO/site-management model directly comparable to TBMR's clinical trial execution services.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tampa Bay Medical Research

Clinical Research Servicestbmr.net

Tampa Bay Medical Research was a Florida-based clinical research organization founded in 1984 that conducted Phase I-IV trials for 70+ pharmaceutical and medical device sponsors across multiple therapeutic areas, including metabolic research. It was acquired by Alcanza Clinical Research in January 2026.

Tampa Bay Medical Research firmographics

Firmographics
Name
Tampa Bay Medical Research
Legal name
Tampa Bay Medical Research
Website
https://tbmr.net
Company type
Private
Founded year
1984
Operating status
Acquired
Headcount range
11–50 employees
Short description
Tampa Bay Medical Research was a Florida-based clinical research organization founded in 1984 that conducted Phase I-IV trials for 70+ pharmaceutical and medical device sponsors across multiple therapeutic areas, including metabolic research. It was acquired by Alcanza Clinical Research in January 2026.
Ownership category
akta.pro rank

Tampa Bay Medical Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Clinical CROs (Phase I–IV) (HLAGAAAA)
akta.pro secondary industry
Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

  • Clinical research services
  • Clinical trial management
  • Metabolic disease research
  • Pharmaceutical trial services
  • Medical device studies

Where Tampa Bay Medical Research is headquartered

Location

Headquarters

HQ city
Clearwater
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Tampa Bay Medical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Distribution channels1 record

Tampa Bay Medical Research product offering

Product offering

Core offering

Tampa Bay Medical Research (TBMR) is a clinical research organization (CRO) that conducts Phase I-IV clinical trials for pharmaceutical and medical device sponsors across multiple therapeutic areas. The organization specializes in metabolic research and operates from facilities in Clearwater and Largo, Florida, totaling more than 5,000 square feet.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phase I-IV Clinical Trials
  • Metabolic Disease Clinical Research
  • Medical Device Clinical Trials

Companies that use Tampa Bay Medical Research

Customer profile

Segments1 record

Ideal customer profiles2 records

Tampa Bay Medical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Tampa Bay Medical Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Alcanza Clinical ResearchcoreStrategic or Co-development Partner · 7 January 2026Strategic partnership in which Alcanza Clinical Research acquired Tampa Bay Medical Research. The transaction integrates TBMR's operational excellence and community presence into Alcanza's network of 25 dedicated research units across the US and Puerto Rico. Westcove Partners served as exclusive financial advisor to Tampa Bay Medical Research.

Scale indicators4 records

Tampa Bay Medical Research competitors and assessment

Company assessment

Broad incumbents

  • Medpace: Mid-to-large global CRO running Phase I-IV trials across therapeutic areas including metabolic and endocrine. Competes for sponsor outsourced trial work though at materially greater scale than TBMR.
  • Syneos Health: Global biopharmaceutical solutions organization offering clinical development services and site management solutions. Comparable end-market positioning to TBMR's clinical trial services business.
  • ICON plc: Global CRO with significant site management (formerly PRA Health, SMO) operations. Operates directly in the same Phase I-IV clinical trial execution category but at an order-of-magnitude larger scale.
  • Thermo Fisher Scientific (PPD): Operates the PPD clinical research business providing end-to-end CRO services including clinical site management. Larger incumbent in clinical trial execution across all therapeutic areas TBMR serves.
  • IQVIA: Largest global CRO and clinical research services provider. Operates dedicated site networks (e.g., Q² Solutions) directly overlapping with TBMR's site-based clinical trial execution model.
  • Fortrea: Spun-out CRO from LabCorp Drug Development offering full-service Phase I-IV clinical trial services. Broadly comparable functional offering to TBMR's clinical research services but with global infrastructure.

Direct peers

  • Meridien Research: Florida-based clinical research site network with a similar mid-sized site profile. Competes for the same regional pharmaceutical sponsor relationships and patient population TBMR serves.
  • Compass Research: Independent clinical research site headquartered in central Florida, conducting Phase I-IV trials across therapeutic areas. Direct competitor for Tampa Bay-area sponsor contracts and patient recruitment pools.
  • Accel Clinical Research: Multi-site independent clinical research organization operating in the southeastern US. Comparable in size, therapeutic breadth, and sponsor mix to TBMR's pre-acquisition profile.
  • Alcanza Clinical Research: Multi-site clinical research network and TBMR's acquirer. Operates dedicated research units across the US and Puerto Rico with a shared CRO/site-management model directly comparable to TBMR's clinical trial execution services.

Market position

Customer concentration

Tampa Bay Medical Research social profiles

Digital presence

Tampa Bay Medical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tampa Bay Medical Research leadership team

Management profile

Number of profiles

Tampa Bay Medical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tampa Bay Medical Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tampa Bay Medical Research

What does Tampa Bay Medical Research do?

Tampa Bay Medical Research (TBMR) is a clinical research organization (CRO) that conducts Phase I-IV clinical trials for pharmaceutical and medical device sponsors across multiple therapeutic areas. The organization specializes in metabolic research and operates from facilities in Clearwater and Largo, Florida, totaling more than 5,000 square feet.

Is Tampa Bay Medical Research a public or private company?

Tampa Bay Medical Research is a private company. It is classified as corporate owned and is currently acquired.

When was Tampa Bay Medical Research founded?

Tampa Bay Medical Research was founded in 1984. It employs 11 to 50 people.

Where is Tampa Bay Medical Research based?

Tampa Bay Medical Research is headquartered in Clearwater, United States, in the North America region.

Who are Tampa Bay Medical Research's main competitors?

Broad incumbents on record are Medpace, Syneos Health, ICON plc, Thermo Fisher Scientific (PPD), IQVIA and Fortrea. Direct peers are Meridien Research, Compass Research, Accel Clinical Research and Alcanza Clinical Research.

Does Tampa Bay Medical Research have an API?

No public API is recorded for Tampa Bay Medical Research.

What industry is Tampa Bay Medical Research in?

Tampa Bay Medical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireWestcove Advises Tampa Bay Medical Research in its Partnership with Alcanza Clinical ResearchTampa Bay Medical Research (TBMR), an independent clinical research organization with facilities in Clearwater and Largo, Florida, has entered into a partnership with Alcanza Clinical Research, a portfolio company of healthcare-focused private equity firm Martis Capital. Westcove Partners served as the exclusive financial advisor to TBMR in the transaction, the terms of which were not disclosed. The partnership is expected to bring scale and infrastructure to support TBMR's continued growth while preserving its existing site strengths.24-7 Press ReleaseAlcanza Clinical Research Announces Strategic Acquisition of Tampa Bay Medical ResearchAlcanza Clinical Research announced the acquisition of Tampa Bay Medical Research, a clinical research center founded in 1984 with a nearly four-decade legacy in advancing medical science and patient care. TBMR has completed more than 600 clinical trials across broad therapeutic areas with over 70 pharmaceutical and medical device sponsors, operating facilities totaling over 5,000 sq ft in Clearwater and Largo, Florida. The acquisition integrates TBMR's operational excellence and community presence into Alcanza's network of 25 dedicated research units across the US and Puerto Rico, expanding its national footprint while preserving TBMR's personalized approach.FinancialContent Business PageAlcanza Clinical Research Announces Strategic Acquisition of Tampa Bay Medical ResearchAlcanza Clinical Research announced the acquisition of Tampa Bay Medical Research (TBMR), a long-standing independent clinical research center founded in 1984 with over 600 completed clinical trials across multiple therapeutic areas. TBMR operates facilities totaling over 5,000 sq ft in Clearwater and Largo, Florida, and brings expertise in metabolic research along with established relationships with over 70 pharmaceutical and medical device sponsors. The acquisition is positioned as a milestone in Alcanza's strategy to expand its national footprint while integrating TBMR's community presence and operational excellence with its scalable infrastructure.